Directed new share issue in Cantargia AB (SE) — SEK 410 million

Carnegie acted as joint bookrunner in the directed new share issue of 18,201,097 new shares at a subscription price of SEK 22.5 per share. Cantargia is a biotechnology company that develops antibody-based treatments for life-threatening diseases. February 2020.